1 week Ago
Revolution Medicines, Inc. ( NASDAQ: RVMD ) Q1 2024 Results Conference Call May 8, 2024 4:30 PM ET Company Participants Erin Graves - Senior Director, Corporate Communications and Investor Relations Dr. Mark Goldsmith - Chairman and Chief Executive Officer Jack Anders - Chief Financial Officer Dr.
Steve Kelsey - President of R&D Dr. Wei Lin - Chief Medical Officer Conference Call Participants Marc Frahm - TD Cowen Michael Schmidt - Guggenheim Securities Eric Joseph - JPMorgan Jonathan Chang - Leerink Partners Ellie Merle - UBS Poorna Kannan - Needham & Company Alec Stranahan - Bank of America Laura Prendergast - Raymond James Ben Burnett - Stifel Operator Good day and thank you for standing by. Welcome to Revolution Medicine's First Quarter 2024 Earnings Conference Call.
At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Erin Graves, Senior Director of Corporate Communications and Investor Relations, please go ahead. Erin Graves Thank you, and welcome, everyone, to the first quarter 2024 earnings call. Joining me on today's call are Dr.
Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer; and Jack Anders, our Chief Financial Officer.; Dr. Steve Kelsey, our President of R&D will also join us for the Q&A portion of t.
